Organigram Rolls out Cannabis 2.0 Products to Medical Consumers
May 28 2020 - 10:48AM
Business Wire
Edison Cannabis Company vape pens and vaporizer
pods, Edison Bytes chocolate now available via Company’s medical
cannabis program
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent
company of Organigram Inc. (the “Company” or “Organigram”), a
leading licensed producer of cannabis, is pleased to announce that
as of May 19th, 2020, the Company has extended its medical cannabis
offering to include products from its cannabis 2.0 adult-use
recreational portfolio.
Products now available to medical cannabis consumers include
ready-to-use Edison Cannabis Company (Edison) vape pens powered by
Feather; Edison-branded pods specifically for PAX Era vaporizers;
and Edison Bytes chocolates in dark and milk chocolate, in both one
and two pack formats.
“Organigram has a deep and long-standing commitment to our
medical cannabis consumers,” says Greg Engel, CEO, Organigram. “As
more and more patients turn their attention to new forms of
cannabis, we are proud to offer them access to an innovative and
growing product portfolio.”
Earlier this year, Organigram announced its first shipments of
Edison vape pens, pods and cannabis-infused chocolate to retailers
across Canada. This follows the Company’s $15 million investment in
a high-speed, high-capacity, fully automated chocolate
manufacturing line.
“We are continuously innovating, responding to the feedback from
customers and building brands that we believe reflect their
evolving needs and preferences. Initial feedback from our medical
consumers has been very positive and we look forward to continuing
to share new products with patients across the country,” says
Engel.
Feedback from the Company’s medical cannabis customers will
continue to help inform product development strategies for medical
consumers moving forward.
Certain of the Company’s cannabis 2.0 products are expected to
be available in the near future through Medical Cannabis by
Shoppers, the online medical cannabis platform of Shoppers Drug
Mart Inc. (Shoppers) in accordance with the terms of the Company’s
supply agreement with Shoppers.
About Organigram Holdings Inc.
Organigram Holdings Inc. is a NASDAQ Global Select and TSX
listed company whose wholly owned subsidiary, Organigram Inc., is a
licensed producer of cannabis and cannabis-derived products in
Canada.
Organigram is focused on producing high-quality, indoor-grown
cannabis for patients and adult recreational consumers in Canada,
as well as developing international business partnerships to extend
the Company's global footprint. Organigram has also developed a
portfolio of legal adult use recreational cannabis brands including
The Edison Cannabis Company, Trailer Park Buds, Ankr Organics and
Trailblazer. Organigram's facility is located in Moncton, New
Brunswick and the Company is regulated by the Cannabis Act and the
Cannabis Regulations (Canada).
This news release contains forward-looking information. Often,
but not always, forward-looking information can be identified by
the use of words such as “plans”, “expects”, “estimates”,
“intends”, “anticipates”, “believes” or variations of such words
and phrases or state that certain actions, events, or results
“may”, “could”, “would”, “might” or “will” be taken, occur or be
achieved. Forward-looking information involves known and unknown
risks, uncertainties and other factors that may cause actual
results, events, performance or achievements of Organigram to
differ materially from current expectations or future results,
performance or achievements expressed or implied by the
forward-looking information contained in this news release. Risks,
uncertainties and other factors involved with forward-looking
information could cause actual events, results, performance,
prospects and opportunities to differ materially from those
expressed or implied by such forward-looking information include
factors that could change anticipated timelines for product
launches and availability; consumer and patient demand and
preferences for products; pricing; and ordering patterns for
various products from time to time and changes thereto including
discontinuing of listings; including general risks related to
COVID-19 and risks as disclosed in the Company’s most recent annual
information form, management’s discussion and analysis and other
Company documents filed from time to time on SEDAR (see
www.sedar.com) and filed or furnished to the Securities and
Exchange Commission on EDGAR (see www.sec.gov). Readers are
cautioned not to place undue reliance on these forward-looking
statements, which speak only as of the date of this press release.
Although the Company believes that the assumptions and factors used
in preparing the forward-looking information in this news release
are reasonable, undue reliance should not be placed on such
information and no assurance can be given that such events will
occur in the disclosed time frames or at all. The forward-looking
information included in this news release are made as of the date
of this news release and the Company disclaims any intention or
obligation, except to the extent required by law, to update or
revise any forward-looking information, whether as a result of new
information, future events or otherwise.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200528005595/en/
For Investor Relations enquiries: Amy Schwalm Vice President,
Investor Relations Amy.Schwalm@organigram.ca (416) 704-9057
For Media enquiries: Ray Gracewood Senior Vice President,
Marketing and Communications rgracewood@organigram.ca (506)
645-1653
Organigram (NASDAQ:OGI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Organigram (NASDAQ:OGI)
Historical Stock Chart
From Apr 2023 to Apr 2024